Focused Wealth Management, Inc - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 53 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$131
+50.6%
2220.0%0.00%
Q4 2022$872220.0%0.00%
Q3 2022$0222
+909.1%
0.00%
Q2 2022$0220.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 129,891$69,0000.01%
Hudson Bay Capital Management LP 230,000$123,0000.00%
Renaissance Technologies 1,879,137$1,004,0000.00%
ROYAL BANK OF CANADA 89$00.00%
Gradient Investments LLC 63$00.00%
VANGUARD GROUP INC 858,416$459,0000.00%
OPTIMUM INVESTMENT ADVISORS 16$00.00%
Focused Wealth Management, Inc 222$00.00%
FEDERATED HERMES, INC. 907$1,0000.00%
JANE STREET GROUP, LLC 24,985$13,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders